Aptinyx Investor Relations Material
Latest events
Q3 2022
Aptinyx
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Aptinyx Inc
Access all reports
Aptinyx Inc. is a biopharmaceutical company focused on developing therapies for neurological disorders. The company leverages its expertise in small-molecule compounds that modulate NMDA receptors to address conditions such as chronic pain, post-traumatic stress disorder, and cognitive impairment. Aptinyx’s research and development efforts aim to create innovative treatments for patients with unmet medical needs. The company is headquartered in Evanston, Illinois, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
APTX
Country
🇺🇸 United States